Value of cerebral blood flow quantification in the diagnosis of dementia

Nuclear Medicine Communications

Volumn 29, Issue 3, 2008, Pages 260-269

  Zaknun, John J ^a   Leblhuber, Friedrich ^a   Schücktanz, Harald ^b  

^a Nuclear Medicine Section   (Australia)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Cerebral blood flow; Dementia; Graphical analysis; Quantification; Technetium 99m hexamethylpropylene amine oxime

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; ATROPHY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HEMISPHERE; HUMAN; IMAGING; LEUKOENCEPHALOPATHY; LEWY BODY; MALE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULAR DISEASE;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 41849105373     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f38f8f     Document Type: Article

References (44)

1. Devous MD, Stockely EM, Chehabi HH, Bonte FJ. Normal distribution of regional cerebral blood flow measured by dynamic single emission tomography. J Cereb Blood Flow Metab 1986; 6:95-104.
2. Iiada H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994; 35:2019-2030.
3. 123]-iodoamphetamine and single-photon emission computed tomography. J Cereb Blood Flow Metab 1996; 16:781-793.
4. Ohkubo M, Odano I, Takahashi M. A comparative study of simple methods to measure regional cerebral blood flow using iodine-123-IMP SPECT. J Nucl Med 1997; 38:597-601.
5. Takeshita G, Maeda H, Nakane K, Toyama H, Sakakibara E, Komai S, et al. Quantitative measurement of regional cereral blood flow using N-isopropyl-(iodine-123)p-iodoamphetamine and single-photon emission computed tomography. J Nucl Med 1992; 33:1741-1749.
6. Tsuchida T, Sadato N, Yonekura Y, Yamamoto K, Waki A, Sugimoto K, et al. Quantification of regional cerebral blood flow with continuous infusion of technetium-99m-ethyl cysteinate dimer. J Nucl Med 1997; 38:1699-1702.
7. 99mTc-ECD SPECT and continuous arterial blood sampling. Ann Nucl Med 1996; 10:177-183.
8. Matsuda H, Tsuiji S, Shuke N, Sumiya H, Tonami N, Hisaka K. A quantitative approach to technetium 99m hexamethylpropylene amine oxime. Eur J Nucl Med 1992; 19:195-200.
9. Matsuda H, Tsuiji S, Shuke N, Sumiya H, Tonami N, Hisada K. Non-invasive measurements of regional cerebral blood flow using technetium-99m hexamethyl propylene amine oxime. Eur J Nucl Med 1993; 20:391-401.
10. Matsuda H, Yagishita A, Tsuiji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylenepropyleneamine oxime. Eur J Nucl Med 1995; 22:633-637.
11. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR Jr. Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computer tomographic, nuclear magnetic resonance, and clinical correlations. Arch Neurol 1985; 42:951-959.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
13. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113-1124.
14. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260.
16. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NT, Gvozdanovic D, et al. Technetium-99m-HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: Human volunteer Studies. J Nucl Med 1986; 27:171-177.
17. Zaknun JJ, Prechtl S, Wasmayr S, Schnizer M. Qualitätssicherung radiochemischer Reinheit (RCR) des CERETEC. Ein Jahr Erfahrung mit routinemäßigen Qualitätskontrollen und Korrelation mit SPECT Bildqualität. Empfehlung für untere Grenzwerte [Abstract]. Nuklearmedizin 2001; 40:A10.
18. Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto S. A practical method for position dependent Compton scatter correction in single photon emission CT. IEEE Trans Nucl Med 1991; 10:408-412.
19. 99mTc-ECD: a study in healthy volunteers. Eur J Nucl Med 2001; 28:862-872.
20. Zaknun J, Lebelhuber L, Aichner FT. Brain mean hemispheric blood flow (mhBF) by HMPAO radionuclide angiography in healthy subjects vs. primary degenerative or microvascular subcortical dementia [Abstract]. J Nucl Med 2001; 5:223P.
21. Kety S. Human cerebral blood flow and oxygen consumption as related to aging. J Chronic Dis 1956; 3:478-486.
22. 99mTc-d, l-HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab 1991; 11:508-521.
23. Yammaguci T, Kanno I, Uemura K, Shishido F, Inugami A, Ogawa T, et al. Reduction in cerebral metabolic rate of oxygen during human aging. Stroke 1986; 17:1220-1228.
24. Dastur DK. Cerebral blood flow and metabolism in normal human aging, pathological aging and senile dementia. J Cereb Blood Flow Metab 1985; 5:1-9.
25. Meltzer CC, Cantwell MN, Greer PJ, Ben-Eliezer D, Smith G, Frank G, et al. Does cerebral blood flow decline in healthy aging? A PET Study with partial-volume correction. J Nucl Med 2000; 41:1842-1848.
26. 15O and positron emission tomography: theory procedure and normal values. J Comput Assist Tomogr 1980; 4:727-736.
27. Pantano P, Baron J-C, Lebrun-Granidié P, Duquensnov N, Bousser M-G, Comar D. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1984; 15:635-641.
28. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJR, et al. Cerebral blood flow, blood volume and oxygen consumption. Brain 1990; 113:27-47.
29. Naritomi H, Meyer JS, Sakai F, Yamaguchi F, Shaw T. Effects of advancing age on regional cerebral blood flow. Studies in normal subjects and subjects with risk factors for atherothrombotic stroke. Arch Neurol 1979; 36:410-416.
30. Melamed E, Lavy S, Bentin S, Cooper G, Rinot Y. Reduction in regional cerebral blood flow during normal aging in man. Stroke 1980; 11:31-35.
31. Matsuda H, Maeda T, Yamada M, Luo X-G, Tonami N, Hisada K. Aged-matched normal values and topographic maps for regional cerebral blood flow measurements by Xe-133 inhalation. Stroke 1984; 15:336-342.
32. Shaw TG, Mortel KF, Meyer JS, Rogers RL, Hardenberg J, Cutaia MM. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 1984; 34:855-862.
33. Komatani A, Yamaguchi K, Kera M. Cerebral blood flow and brain size in healthy subjects - sensitivity to age and gender. No To Shinkei 1990; 42:889-893.
34. Morrison JH, Hof PR. Life and death of neurons in aging brain. Science 1997; 278:412-419.
35. Huttenlocher PR. Synaptic density in human fronatal cortex - developmental changes and effect of aging. Brain Res 1979; 163:195-205.
36. Terry HD, DeTeresa R, Hansen LA. Neocortical cell counts in normal adult aging. Ann Neurol 1987; 21:530-539.
37. Tachibana H, Kaku T, Takeda M, Tsuchiyama M, Toda K, Kawabata K, et al. Periventricular lucencies on computed tomography in multiple cerebral infarcts: correlation with cerebral blood flow measurements. Int J Neurosci 1990; 53:191-197.
38. Orgogozo JM, Larsen B, Skyhoj E, Lassen NA. Evidence of cortical disconnection in deep hemispheric strokes as revealed by rCBF. Acta Neurol Scand 1979; 60 (suppl 72):258-259.
39. Ohm TG, Scharnagl H, Marz W, Bohl J. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol (Berl) 1999; 98:273-280.
40. Tolnay M, Probst A. Review: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 1999; 25:171-187.
41. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 2001; 49:175-184.
42. Kosaka K, Iseki E. Clinicopathological studies on diffuse Lewy body disease. Neuropathology 2000; 20:1-7.
43. Yoshiyama Y, Lee VM, Trojanowski JQ. Frontotemporal dementia and tauopathy. Curr Neurol Neurosci Rep 2001; 1:413-421.
44. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, et al. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994; 21:1052-1060.